Literature DB >> 17156501

Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort.

D B Scheurer1, L S Hicks, E F Cook, J L Schnipper.   

Abstract

Clostridium difficile (C. diff) is a major nosocomial problem. Epidemiological surveillance of the disease can be accomplished by microbiological or administrative data. Microbiological tracking is problematic since it does not always translate into clinical disease, and it is not always available. Tracking by administrative data is attractive, but ICD-9 code accuracy for C. diff is unknown. By using a large administrative database of hospitalized patients with C. diff (by ICD-9 code or cytotoxic assay), this study found that the sensitivity, specificity, positive, and negative predictive values of ICD-9 coding were 71%, 99%, 87%, and 96% respectively (using micro data as the gold standard). When only using symptomatic patients the sensitivity increased to 82% and when only using symptomatic patients whose test results were available at discharge, the sensitivity increased to 88%. C. diff ICD-9 codes closely approximate true C. diff infection, especially in symptomatic patients whose test results are available at the time of discharge, and can therefore be used as a reasonable alternative to microbiological data for tracking purposes.

Entities:  

Mesh:

Year:  2006        PMID: 17156501      PMCID: PMC2870650          DOI: 10.1017/S0950268806007655

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  11 in total

1.  Evaluation of coding data quality of the HCUP National Inpatient Sample.

Authors:  C L Berthelsen
Journal:  Top Health Inf Manage       Date:  2000-11

2.  Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001.

Authors:  Lennox K Archibald; Shailen N Banerjee; William R Jarvis
Journal:  J Infect Dis       Date:  2004-04-20       Impact factor: 5.226

3.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

Authors:  Vivian G Loo; Louise Poirier; Mark A Miller; Matthew Oughton; Michael D Libman; Sophie Michaud; Anne-Marie Bourgault; Tuyen Nguyen; Charles Frenette; Mirabelle Kelly; Anne Vibien; Paul Brassard; Susan Fenn; Ken Dewar; Thomas J Hudson; Ruth Horn; Pierre René; Yury Monczak; André Dascal
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

4.  An epidemic, toxin gene-variant strain of Clostridium difficile.

Authors:  L Clifford McDonald; George E Killgore; Angela Thompson; Robert C Owens; Sophia V Kazakova; Susan P Sambol; Stuart Johnson; Dale N Gerding
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

5.  A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.

Authors:  Carlene A Muto; Marian Pokrywka; Kathleen Shutt; Aaron B Mendelsohn; Kathy Nouri; Kathy Posey; Terri Roberts; Karen Croyle; Sharon Krystofiak; Sujata Patel-Brown; A William Pasculle; David L Paterson; Melissa Saul; Lee H Harrison
Journal:  Infect Control Hosp Epidemiol       Date:  2005-03       Impact factor: 3.254

6.  Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Authors:  L Kyne; M Warny; A Qamar; C P Kelly
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

7.  Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.

Authors:  Lorraine Kyne; Mary Beth Hamel; Rajashekhar Polavaram; Ciarán P Kelly
Journal:  Clin Infect Dis       Date:  2001-12-17       Impact factor: 9.079

8.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors:  Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

9.  ICD-9 codes and surveillance for Clostridium difficile-associated disease.

Authors:  Erik R Dubberke; Kimberly A Reske; L Clifford McDonald; Victoria J Fraser
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

10.  Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003.

Authors:  L Clifford McDonald; Maria Owings; Daniel B Jernigan
Journal:  Emerg Infect Dis       Date:  2006-03       Impact factor: 6.883

View more
  40 in total

1.  Obesity Is Associated with Decreased Risk of Clostridium difficile Infection in Hospitalized Patients with Pouchitis.

Authors:  Falgun Gosai; Fahrettin Covut; Mohammad Alomari; Asif Hitawala; Amandeep Singh; Gaurav Kisangani; Rocio Lopez; Bo Shen
Journal:  Dig Dis Sci       Date:  2019-10-15       Impact factor: 3.199

2.  Increasing ultraviolet light exposure is associated with reduced mortality from Clostridium difficile infection.

Authors:  Shail M Govani; Akbar K Waljee; Ryan W Stidham; Peter Dr Higgins
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

3.  Validity and Reliability of Administrative Coded Data for the Identification of Hospital-Acquired Infections: An Updated Systematic Review with Meta-Analysis and Meta-Regression Analysis.

Authors:  Olga Redondo-González; José María Tenías; Ángel Arias; Alfredo J Lucendo
Journal:  Health Serv Res       Date:  2017-04-11       Impact factor: 3.402

4.  Patient Mortality During Unannounced Accreditation Surveys at US Hospitals.

Authors:  Michael L Barnett; Andrew R Olenski; Anupam B Jena
Journal:  JAMA Intern Med       Date:  2017-05-01       Impact factor: 21.873

5.  The Validity of HCC Diagnosis Codes in Chronic Hepatitis B Patients in the Veterans Health Administration.

Authors:  Ronald Omino; Sahil Mittal; Jennifer R Kramer; Maneerat Chayanupatkul; Peter Richardson; Fasiha Kanwal
Journal:  Dig Dis Sci       Date:  2017-03-07       Impact factor: 3.199

6.  The impact of ICD-9-CM code rank order on the estimated prevalence of Clostridium difficile infections.

Authors:  Erik R Dubberke; Anne M Butler; Humaa A Nyazee; Kimberly A Reske; Deborah S Yokoe; Jeanmarie Mayer; Julie E Mangino; Yosef M Khan; Victoria J Fraser
Journal:  Clin Infect Dis       Date:  2011-07-01       Impact factor: 9.079

7.  Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.

Authors:  Brian T Bateman; Jeremy A Rassen; Sebastian Schneeweiss; Katsiaryna Bykov; Jessica Myers Franklin; Joshua J Gagne; Jennifer M Polinski; Jun Liu; Alexander Kulik; Michael A Fischer; Niteesh K Choudhry
Journal:  J Thorac Cardiovasc Surg       Date:  2013-03-28       Impact factor: 5.209

8.  Michigan Clostridium difficile hospital discharges: frequency, mortality, and charges, 2002-2008.

Authors:  Kerrie E VerLee; Jennie L Finks; Melinda J Wilkins; Eden V Wells
Journal:  Public Health Rep       Date:  2012 Jan-Feb       Impact factor: 2.792

9.  The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease.

Authors:  S K Hourigan; M Oliva-Hemker; S Hutfless
Journal:  Dig Dis Sci       Date:  2014-05-01       Impact factor: 3.199

10.  Hospital Clostridium difficile Infection Rates and Prediction of Length of Stay in Patients Without C. difficile Infection.

Authors:  Aaron C Miller; Linnea A Polgreen; Joseph E Cavanaugh; Philip M Polgreen
Journal:  Infect Control Hosp Epidemiol       Date:  2016-02-09       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.